Organization
CureLab Oncology
1 clinical trial
Clinical trial
Open Label Randomized Clinical Study of Plasmid Encoding p62/SQSTM1 (ELenagen) in in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian CancerStatus: Active (not recruiting), Estimated PCD: 2024-12-30